171
Participants
Start Date
April 29, 2018
Primary Completion Date
September 28, 2021
Study Completion Date
December 5, 2022
Wisepill device
"Participants will receive a Wisepill device for TB and ART medications. Participants will receive an exit counselling session prior to being discharged.~Participants will select the content of a text message to be sent when missing a dose as measured by Wisepill non-opening during medication dose-window.~Participants will receive a post-discharge phone call by study staff for the purpose of identifying any early challenges or obstacles. All participants may receive a titrated Wisepill intervention (TWI) consisting of a text message, phone call, and/or study home visit triggered by medication non-adherence as detected by Wisepill non-opening.~All participants will receive a monthly counselling intervention (MCI). Adherence support groups (ASG) will be conducted on a monthly basis."
King Dinuzulu Hospital, Durban
Columbia University
OTHER
Centre for the AIDS Programme of Research in South Africa
NETWORK